Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine. 2018

Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora.

We studied the relationship between varicella-zoster virus (VZV) DNAemia and development of VZV-specific immunity after administration of live-attenuated zoster vaccine. VZV-DNAemia, detected by polymerase chain reaction (PCR), and VZV-specific effector (Teff) and memory (Tmem) T cells, was measured in 67 vaccinees. PCR was positive in 56% (9 direct, 28 nested) on day 1 and in 16% (1 direct, 10 nested) on day 14. Teff progressively increased in direct-PCR-positive vaccinees up to day 30, but Tmem did not. Conversely, Tmem, but not Teff, increased in direct-PCR-negative vaccinees on day 7. The kinetics of these immune responses and VZV DNAemia suggested that direct-PCR sample positive represented viremia.

UI MeSH Term Description Entries
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated
D014645 Herpesvirus 3, Human The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. Chickenpox Virus,Herpes zoster Virus,Ocular Herpes zoster Virus,VZ Virus,Varicella-Zoster Virus,HHV-3,Herpesvirus 3 (alpha), Human,Herpesvirus Varicellae,Human Herpesvirus 3,Chickenpox Viruses,Herpes zoster Viruses,VZ Viruses,Varicella Zoster Virus,Varicella-Zoster Viruses,Varicellae, Herpesvirus
D014766 Viremia The presence of viruses in the blood. Viremias
D053061 Herpes Zoster Vaccine An attenuated vaccine used to prevent and/or treat HERPES ZOSTER, a disease caused by HUMAN HERPESVIRUS 3. Shingles Vaccine,Zostavax,Zoster Vaccine,Vaccine, Herpes Zoster,Vaccine, Shingles,Vaccine, Zoster

Related Publications

Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
September 2011, The Journal of infectious diseases,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
April 2012, The Journal of infectious diseases,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
April 1991, The Journal of infectious diseases,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
April 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
January 2019, The Journal of infectious diseases,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
August 2002, European journal of pediatrics,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
August 1995, Journal of neurology, neurosurgery, and psychiatry,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
May 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
May 2005, Nihon rinsho. Japanese journal of clinical medicine,
Myron J Levin, and Guang-Yun Cai, and Katherine S Lee, and Nadine G Rouphael, and Aneesh K Mehta, and Jennifer Canniff, and Mark J Mulligan, and Adriana Weinberg
March 1978, JAMA,
Copied contents to your clipboard!